Infectious Prophylaxis in Pediatric Oncology and Stem Cell Transplantation

Research output: Contribution to journalReview articlepeer-review


The advances in the survival of children with cancer and following stem cell transplant have, in part, been due to more effective infection prevention strategies. Morbidity and mortality following bacterial, viral and fungal infection remain significant necessitating further refinement of existing prophylactic strategies. Novel antiviral agents, newer and better tolerated antifungal drugs, antibiotic bacterial prophylaxis and adoptive immunotherapy in high-risk groups are potential approaches for which supportive evidence is emerging. Questions remain as to the optimal approach to infectious prophylaxis using currently available agents. There is a clear need for further directed paediatric research in this area.

Original languageEnglish
Pages (from-to)160-169
Number of pages10
Journal Current Pediatrics Reports
Issue number2
Publication statusPublished - 2015


Dive into the research topics of 'Infectious Prophylaxis in Pediatric Oncology and Stem Cell Transplantation'. Together they form a unique fingerprint.

Cite this